Kidney transplant rejection occurs when the body’s immune system recognizes a newly transplanted kidney as a foreign object and attempts to attack it, potentially causing damage to the organ. While transplantation offers renewed hope for people with severe kidney disease, rejection remains a significant challenge that requires careful monitoring and lifelong management.

Epidemiology

Kidney transplant rejection is a relatively common complication following transplant surgery. Research shows that approximately 15 to 20 percent of people who receive a new kidney will experience some degree of rejection.^[1] The severity of rejection episodes varies widely from one patient to another, with some experiencing mild forms that respond well to treatment, while others face more serious challenges.

The risk of rejection is not constant over time. Acute rejection is most likely to occur within the first six months after transplant surgery, particularly within the initial weeks following the procedure.^[1] However, the possibility of rejection never completely disappears. While the risk decreases as time passes, rejection episodes can happen years after the transplant, especially in cases of chronic rejection which develops slowly over several years.^[1]

About 10 to 20 percent of transplant recipients will experience at least one episode of rejection.^[8] Despite these statistics, it’s important to understand that experiencing rejection does not automatically mean the transplanted kidney will be lost. Most rejection episodes can be successfully treated, particularly when detected early through routine monitoring.

Causes

The root cause of kidney transplant rejection lies in the fundamental way our bodies protect themselves from harm. The immune system, which is the body’s natural defense mechanism, constantly surveys for threats such as bacteria, viruses, and other foreign substances. When a new kidney is transplanted into someone’s body, the immune system recognizes it as “foreign” or “non-self” because it comes from another person.^[1]

Even when a donor kidney is carefully matched to the recipient based on blood type and tissue type (genetic markers called human leukocyte antigens, or HLA), some degree of genetic difference almost always exists. The exception to this rule would be identical twins, who share the exact same genetic makeup. For everyone else, the transplanted kidney carries molecular signatures that differ from the recipient’s own tissues.^[3]

The immune system employs multiple mechanisms to respond to the transplanted kidney. T lymphocytes, which are specialized white blood cells, play a principal role in recognizing the foreign kidney.^[3] These cells can infiltrate the kidney tissue and trigger inflammation and damage. Additionally, the body can produce antibodies, which are proteins that target specific features on the donor kidney’s cells. When these antibodies attach to the kidney’s blood vessels and tissues, they can cause injury through various pathways.^[3]

The rejection process is essentially the immune system doing what it was designed to do: protecting the body from what it perceives as an invader. Unfortunately, in the case of a life-saving transplant, this protective response works against the patient’s best interests. This is why medications that suppress the immune system are absolutely necessary for transplant recipients.

Risk Factors

Several factors can increase the likelihood of experiencing kidney transplant rejection. One of the most significant risk factors is poor adherence to medication. Transplant recipients must take immunosuppressant medications (also called anti-rejection drugs) every single day, exactly as prescribed. Missing even one dose can allow the immune system to begin attacking the transplanted kidney.^[1] Patients who forget to take their medications regularly or who stop taking them without medical guidance face a much higher risk of rejection.

The degree of genetic matching between donor and recipient also influences rejection risk. Greater differences in HLA markers between donor and recipient can lead to a stronger immune response. In some cases, recipients may have already developed antibodies against donor tissue before transplantation, which can complicate the situation.^[3]

Infections can trigger immune responses that may increase the risk of rejection. When the body fights off an infection, the immune system becomes more active overall, which can inadvertently lead to increased activity against the transplanted kidney as well.^[3] This is one reason why transplant recipients need to be particularly careful about preventing infections.

Previous episodes of acute rejection increase the risk of future rejection events and can contribute to long-term kidney damage.^[10] Additionally, certain medical complications during or immediately after transplant surgery, such as problems with blood flow to the kidney, can increase rejection risk.

Symptoms

One of the most challenging aspects of kidney transplant rejection is that many episodes occur without obvious symptoms. In fact, most rejection episodes are discovered through routine blood testing rather than through symptoms that patients notice themselves.^[8] This type of rejection without symptoms is sometimes called silent rejection or subclinical acute rejection. By the time symptoms appear, some degree of damage may have already occurred to the kidney.

When symptoms do develop, they can vary from person to person. One of the most common signs is fever, particularly a temperature higher than 100 or 101 degrees Fahrenheit (about 38 degrees Celsius).^[1] This fever may be accompanied by flu-like symptoms such as chills, body aches, headache, dizziness, or general feelings of being unwell.^[5]

Pain or tenderness around the area where the kidney was transplanted is another possible warning sign. The transplanted kidney is typically placed in the lower abdomen, and patients may notice discomfort or pain in this region if rejection is occurring.^[1]

Changes in urination patterns can also signal rejection. Patients may notice they are producing less urine than usual, which indicates the kidney is not filtering waste products as effectively as it should.^[1] Swelling, particularly in the legs, ankles, or feet, can develop when the kidney is not removing excess fluid from the body properly.

Sudden weight gain is another concerning symptom, especially if someone gains 2 to 4 pounds or more within a 24-hour period.^[1] This rapid weight increase is typically due to fluid retention rather than actual body tissue gain. Some patients also experience nausea or vomiting during a rejection episode.^[5]

Fatigue and general weakness may accompany rejection as well. Patients might feel more tired than usual or lack their normal energy levels. It’s crucial to understand that these symptoms are not specific to rejection alone and can be caused by other medical problems. However, any of these warning signs should prompt immediate contact with the transplant team.

Prevention

Preventing kidney transplant rejection requires a comprehensive, lifelong commitment to health management. The cornerstone of rejection prevention is faithful adherence to immunosuppressant medications. These drugs work by dampening the immune system’s response, making it less likely to attack the transplanted kidney. Every transplant recipient must take these medications exactly as prescribed, at the same times each day, without missing doses.^[1]

Different combinations of immunosuppressant medications are used, and the specific regimen is tailored to each patient’s needs. Common medications include cyclosporine, tacrolimus, azathioprine, mycophenolate mofetil, and prednisone, among others.^[6] The transplant team will monitor blood levels of these medications regularly and adjust doses as needed to maintain the right balance between preventing rejection and avoiding excessive immune suppression, which could lead to infections.

Regular medical follow-up is absolutely essential for rejection prevention. Transplant recipients need frequent blood tests, especially in the first months after surgery, to monitor kidney function and detect any early signs of rejection before symptoms appear.^[1] These blood tests measure substances like creatinine, which is a waste product that builds up when the kidneys are not working properly. Rising creatinine levels can indicate rejection or other kidney problems.

Maintaining a healthy lifestyle supports overall health and helps protect the transplanted kidney. This includes eating a balanced diet that is low in salt and fat, staying well-hydrated by drinking plenty of water, and incorporating regular physical activity into daily routines as directed by healthcare providers.^[5] For patients with diabetes, careful blood sugar management is particularly important.

Infection prevention is another critical aspect of protecting the transplanted kidney. Transplant recipients should wash their hands frequently and thoroughly, stay away from people who are sick, and avoid exposure to germs whenever possible.^[5] Some infections can trigger immune responses that increase rejection risk, and immunosuppressed patients are more vulnerable to infections in general.

Stress management and attention to mental health also play a role in overall well-being after transplant. Patients should watch for signs of depression or anxiety and seek support when needed.^[5] The emotional and psychological aspects of living with a transplant can be challenging, and addressing these concerns helps patients maintain the healthy behaviors necessary for long-term success.

Pathophysiology

Understanding how rejection damages the transplanted kidney requires looking at what happens at the cellular and tissue level. The rejection process involves complex interactions between different components of the immune system and the structures within the kidney.

When the immune system recognizes the transplanted kidney as foreign, several types of immune responses can occur. In T-cell-mediated rejection (also called cellular rejection), T lymphocytes migrate into the kidney tissue. These immune cells infiltrate the spaces between kidney tubules (tiny tubes that process urine) and can even attack the walls of small blood vessels within the kidney.^[3] This infiltration causes inflammation and disrupts the kidney’s normal architecture and function.

In antibody-mediated rejection, the immune system produces antibodies specifically targeted against proteins on the donor kidney’s cells. These antibodies attach to the inner lining of blood vessels within the kidney, a layer called the endothelium.^[3] Once antibodies bind to these cells, they activate other immune system components, including the complement system, which is a group of proteins that normally help destroy bacteria but can also damage transplanted tissue. This process leads to inflammation of the small blood vessels that supply the kidney, a condition called capillaritis, and inflammation in the kidney’s filtering units, called glomerulitis.^[3]

Different types of rejection occur at different times and cause distinct patterns of damage. Hyperacute rejection is a severe form that happens within minutes to hours after transplant if the recipient already has antibodies against the donor kidney. This type is rare today because of careful pre-transplant testing and matching.^[3]

Acute rejection typically occurs within the first year after transplant, most commonly in the first few months. It can involve T-cells, antibodies, or both. Acute rejection causes rapid changes in kidney function that can usually be detected through blood tests and confirmed through kidney biopsy. With prompt treatment, most acute rejection episodes can be reversed without permanent damage.^[1]

Chronic rejection is a slower, more insidious process that develops over months to years. It involves progressive scarring of kidney tissue, thickening of blood vessel walls, and gradual loss of functioning kidney units. The immune system’s constant low-level attack on the kidney leads to cumulative damage that eventually impairs the organ’s ability to filter blood and produce urine.^[1] Chronic rejection is more difficult to treat than acute rejection and is a major cause of late transplant failure.

The mechanical and physical changes in the rejected kidney include swelling due to inflammation, disruption of the delicate filtering structures, and scarring of tissue. Biochemically, the inflammatory process releases various signaling molecules called cytokines that amplify the immune response and attract more immune cells to the kidney. The kidney’s normal functions, such as filtering waste products, regulating fluid and salt balance, and producing hormones, become progressively impaired as rejection damage accumulates.